Place in the Sulfonamide Classification
To understand the characteristics of sulfacetamide, one must review the general classification of the group. Sulfonamides are divided into agents for resorptive (systemic) and local action.
Resorptive agents are well absorbed from the gastrointestinal tract and classified by their half-life ($t_{1/2}$):
- Short-acting ($t_{1/2} < 10$ h): sulfanilamide (streptocide), sulfathiazole, sulfacarbamide (urosulfan), sulfadimidine. Prescribed frequently, 4–6 times daily.
- Intermediate-acting ($t_{1/2}$ 10–24 h): sulfadiazine, sulfamethoxazole.
- Long-acting ($t_{1/2}$ 24–48 h): sulfadimethoxine, sulfamonomethoxine, sulfamethoxypyridazine.
- Ultratong-acting ($t_{1/2} > 48$ h): sulfalene.
Sulfacetamide (Sulfacylum-natrium) belongs to the group of topical agents. This subgroup also includes silver sulfadiazine. They are used topically as eye drops, ointments, and creams.
Pharmacokinetics and Mechanism of Action
When applied topically in ophthalmology, sulfacetamide penetrates well into ocular tissues and fluids. An important pharmacokinetic nuance frequently tested in exams: when the conjunctiva is inflamed, systemic absorption of the drug into the bloodstream can occur.
For comparison: when dealing with systemic urinary tract infections (UTIs), other short-acting sulfonamides such as urosulfan are the drugs of choice. They undergo minimal acetylation and are excreted unchanged by the kidneys, achieving high concentrations in the urine. Sulfacetamide, however, is the drug of choice specifically for localized action on the mucous membranes of the eye.
Indications and Dosing Regimen
The primary clinical field for the drug is ophthalmology. Sulfacylum-natrium is indicated for the treatment of the following infectious and inflammatory conditions:
- Conjunctivitis;
- Blepharitis;
- Purulent corneal ulcers.
Dosing regimen for ophthalmic forms: the drug is instilled as 1–2 drops 4–6 times daily into the conjunctival sac, utilizing 10%–30% solutions.
Despite its prominent local profile, prescription references retain dosage information for systemic administration:
- Oral: 0.5–1.0 g;
- Intravenous slow injection: 0.9–1.5 g.
Side Effects and Therapy Management
The tolerability of sulfacetamide is generally considered good. The main clinical issue is local irritation, which occurs when using high-concentration solutions (e.g., 30%).
Symptoms of local irritation include:
- Burning;
- Itching;
- Lacrimation;
- Stinging in the eyes.
Management rule: if these irritation symptoms appear, the drug should not be discontinued; instead, switch to instilling lower-concentration solutions (e.g., reducing from 30% to 20% or 10%).
Available Dosage Forms
For correct prescription writing in pharmacology, it is necessary to know the relevant dosage forms:
- Powder;
- 30% solution in 5 ml ampoules;
- 30% solution in 5 ml and 10 ml bottles;
- 20% eye drops in 1.5 ml dropper tubes;
- Ointments (mentioned in guidelines for topical application).